The results of a joint computational and experimental study of the cyclometallation reactions of dimethylbenzylamine (DMBA-H) with [IrCl(2)Cp*](2) and a range of chelating bases are presented. With acetate, density functional theory calculations on the key intermediate, [Ir(DMBA-H)(kappa(2)-OAc)Cp](+), define a two-step C-H activation process involving initial kappa(2)-kappa(1) displacement of base to give an intermediate that is stabilized by internal H-bonding. Facile C-H bond cleavage then occurs via 'ambiphilic metal ligand activation' (AMLA). A similar pattern is computed for other carboxylates and bicarbonate, and in each case the ease of C-H activation is governed by the accessibility of the kappa(2)-kappa(1) base displacement step; thus, more weakly coordinating bases promote C-H activation. For triflate, [Ir(DMBA-H)(kappa(1)-CF(3)SO(3))Cp](+) is more stable than its kappa(2)-isomer and C-H activation proceeds with a barrier of only 3.8 kcal mol(-1). Experimental studies confirm that a range of carboxylates and triflate can effect cyclometallation; however, reactivity patterns are not consistent with the computed C-H activation barriers. Instead, the role of base in opening the [IrCl(2)Cp*](2) dimer and subsequent formation of the [Ir(DMBA-H)(base)Cp*](+) intermediates appears crucial. Calculations indicate these processes are far more favourable for acetate than for triflate.
No takes yet. Share an insight, caveat, or question.
Boutadla et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: